The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
February 3, 1983
Study Completion Date
December 10, 2007
Conditions
GastrinomaZollinger Ellison Syndrome
Interventions
DRUG
Pantoprazole
DRUG
Omeprazole
Trial Locations (1)
20892
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
All Listed Sponsors
lead
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
NCT00001191 - The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid | Biotech Hunter | Biotech Hunter